HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Thomas J. Von Rueden Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Borkon, A. M. Articles by Morrow, A. G. Search for Related Content PubMed PubMed Citation Articles by Borkon, A. M. Articles by Morrow, A. G.

Ann Thorac Surg 1981;32:127-137
© 1981 The Society of Thoracic Surgeons

---

Articles

Mitral Valve Replacement with the Hancock Bioprosthesis: Five- to Ten-Year Follow-up

Clinic of Surgery, National Heart Institute, Bethesda, MD

^* Address reprint requests to Dr. Morrow, National Heart Institute, Bethesda, MD 20205

One hundred eleven patients undergoing mitral valve replacement, either alone (56) or in conjunction with another type of prosthetic valve, prior to 1975 were evaluated. Hospital mortality was 9.9%. Cumulative follow-up is 505 patient-years (mean, 5.4 years). Seventy patients have been followed between 5 and 10 years. Late mortality for mitral valve replacement alone is 4.3 ± 1.3% per patient-year; actuarial survival is 82 ± 6% at 5 years and 65 ± 11% at 10 years. The incidence of emboli was 3.3 ± 0.9% per patient-year for all patients with bioprostheses (62) and 4.2 ± 1.7% per patient-year for bioprostheses and concomitant mechanical aortic valves (32). In patients with only bioprostheses, two of twelve emboli occurred within the first 6 postoperative months and there were three fatal cerebral emboli (0.8 + 0.5% per patient-year). The incidence of hemorrhagic complications is 4.9 ± 1.9% for anticoagulated patients with bioprostheses and mechanical aortic valves; one hemorrhage was fatal (0.7 ± 0.7% per patient-year). Intrinsic mitral bioprosthesis failure occurred in 10 patients; 2 died. Five patients had valve failure secondary to perivalvular regurgitation (3) or endocarditis (2). Actuarial late survival free from intrinsic mitral bioprosthetic failure was 99 ± 1% at 5 years, 92 ± 4% at 7 years, 70 ± 12% at 9 years, and 61 ± 13% at 10 years.

It is unknown at the present time whether the long-term risk of late intrinsic valve failure and reoperation will outweigh the low incidence of emboli and avoidance of anticoagulant-related hemorrhage. Until further information becomes available, the Hancock bioprosthesis is used for mitral valve replacement only in patients older than 60 years or in patients with contraindications for anticoagulant therapy.

This article has been cited by other articles:

				J. Fernandez, C. Chen, J. Gu, O. B. Brdlik, G. W. Laub, M. M. Murphy, M. S. Adkins, W. A. Anderson, and L. B. McGrath Comparison of low-pressure versus standard-pressure fixation carpentier-Edwards bioprosthesis Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S205 - S210. [Abstract] [PDF]

				A. D. Milano, U. Bortolotti, A. Mazzucco, F. Guerra, G. Stellin, E. Talenti, G. Thiene, and V. Gallucci Performance of the Hancock Porcine Bioprosthesis Following Aortic Valve Replacement: Considerations Based on a 15-Year Experience Ann. Thorac. Surg., August 1, 1988; 46(2): 216 - 222. [Abstract] [PDF]

				A. H. Foster, G. J. Greenberg, D. J. Underhill, C. L. McIntosh, and R. E. Clark Intrinsic Failure of Hancock Mitral Bioprostheses: 10- to 15-Year Experience Ann. Thorac. Surg., December 1, 1987; 44(6): 568 - 577. [Abstract] [PDF]

				L. H. Edmunds Jr. Thrombotic and Bleeding Complications of Prosthetic Heart Valves Ann. Thorac. Surg., October 1, 1987; 44(4): 430 - 445. [Abstract] [PDF]

				U. Bortolotti, A. Milano, G. Thiene, F. Guerra, A. Mazzucco, E. Talenti, and V. Gallucci Long-term Durability of the Hancock Porcine Bioprosthesis Following Combined Mitral and Aortic Valve Replacement: An 11-Year Experience Ann. Thorac. Surg., August 1, 1987; 44(2): 139 - 144. [Abstract] [PDF]

				A. Cobanoglu, W. R. E. Jamieson, D. C. Miller, C. McKinley, G. L. Grunkemeier, H. S. Floten, R. T. Miyagishima, G. F. O. Tyers, N. E. Shumway, and A. Starr A Tri-Institutional Comparison of Tissue and Mechanical Valves using a Patient-Oriented Definition of "Treatment Failure" Ann. Thorac. Surg., March 1, 1987; 43(3): 245 - 253. [Abstract] [PDF]

				C. Zussa, G. Ottino, M. di Summa, G. A. Poletti, G. F. Zattera, S. Pansini, and M. Morea Porcine Cardiac Bioprostheses: Evaluation of Long-term Results in 990 Patients Ann. Thorac. Surg., March 1, 1985; 39(3): 243 - 250. [Abstract] [PDF]

				M. P. Brais, J. P. Bedard, W. Goldstein, A. Koshal, and W. J. Keon Ionescu-Shiley Pericardial Xenografts: Follow-up of Up to 6 Years Ann. Thorac. Surg., February 1, 1985; 39(2): 105 - 111. [Abstract] [PDF]

				A. K. Singh Tricuspid Valve Replacement Ann. Thorac. Surg., January 1, 1985; 39(1): 99 - 99. [PDF]

				V. Gallucci, U. Bortolotti, A. Milano, C. Valfre, A. Mazzucco, and G. Thiene Isolated Mitral Valve Replacement with the Hancock Bioprosthesis: A 13-Year Appraisal Ann. Thorac. Surg., December 1, 1984; 38(6): 571 - 578. [Abstract] [PDF]

				S. Gabbay, U. Bortolotti, G. Cipolletti, F. Wasserman, R. W. M. Frater, and S. M. Factor The Meadox Unicusp Pericardial Bioprosthetic Heart Valve: New Concept Ann. Thorac. Surg., June 1, 1984; 37(6): 448 - 456. [Abstract] [PDF]

				M. J. Antunes, M. Med., and L. P. Santos Performance of Glutaraldehyde-Preserved Porcine Bioprosthesis as a Mitral Valve Substitute in a Young Population Group Ann. Thorac. Surg., May 1, 1984; 37(5): 387 - 392. [Abstract] [PDF]

				E. L. Jones The Quest for a Valve Substitute: Perturbations of a Clinical Surgeon Ann. Thorac. Surg., September 1, 1983; 36(3): 243 - 244. [PDF]

				H. Bolooki, S. Mallon, G. A. Kaiser, R. J. Thurer, and J. Kieval Failure of Hancock Xenograft Valve: Importance of Valve Position (4- to 9-Year Follow-up) Ann. Thorac. Surg., September 1, 1983; 36(3): 246 - 252. [Abstract] [PDF]

				L. Gonzalez-Lavin, S. Chi, T. C. Blair, J. Y. Jung, A. G. Fabaz, P. M. McFadden, B. Lewis, and G. Daughters Five-Year Experience with the Ionescu-Shiley Bovine Pericardial Valve in the Aortic Position Ann. Thorac. Surg., September 1, 1983; 36(3): 270 - 280. [Abstract] [PDF]

				M. I. Ionescu, D. R. Smith, S. S. Hasan, M. Chidambaram, and A. P. Tandon Clinical Durability of the Pericardial Xenograft Valve: Ten Years' Experience with Mitral Replacement Ann. Thorac. Surg., September 1, 1982; 34(3): 265 - 277. [Abstract] [PDF]